GSK2879552 Dihydrochloride

GSK2879552 Dihydrochloride is an inhibitor of Histamine Receptors used in studies of GPCR Signaling and Neurotransmission. It is especially relevant in cancer, epigenetics, and inflammation models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics and synaptic signaling, receptor activity, and neuronal excitability.

By inhibiting Histamine Receptors, GSK2879552 Dihydrochloride can be used to examine receptor-driven second-messenger signaling and desensitization dynamics and synaptic signaling, receptor activity, and neuronal excitability. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In cancer, epigenetics, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Histamine Receptors
• Pathway perturbation studies connected to GPCR Signaling and Neurotransmission
• Concentration-response inhibition and target-dependence studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, GSK2879552 Dihydrochloride is appropriate when a defined chemical perturbant is needed to connect Histamine Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, epigenetics, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.